Health Catalyst Inc

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Health Catalyst Inc reports solid 2022 performance and eyes margin growth opportunities

Health Catalyst Inc delivered strong financial performance in 2022, with revenue growth, improved EBITDA, and a positive outlook for 2023. The company's focus on client relationships, tech-enabled services, and margin improvement positions it well for future success. Challenges such as long sales cycles and migration costs are being managed strategically to drive growth.

Health Catalyst beats Q1 revenue targets, eyes tech-enabled growth

Health Catalyst's Q1 2023 performance showed revenue growth and operational efficiency, with a focus on recurring revenue and client relationships.
While facing challenges in the health system market and revenue lumpiness, the company aims for growth through tech-enabled services and cost-saving strategies.
Opportunities lie in expanding into the ambulatory space, offering modular solutions, and investing in tech capabilities for long-term differentiation and client value.
Overall, Health Catalyst remains cautious about expansion, prioritizing being a differentiated long-term partner to effectively deliver for clients.

Health Catalyst beats Q2 expectations, eyes growth in managed services

Health Catalyst's Q2 performance exceeded expectations, with raised guidance for 2023.
Focus on tech-enabled managed services and long-term client relationships driving growth.
Challenges include longer sales cycles and improving gross margins in contracts.
Opportunities lie in margin improvement, summit impact on bookings, and clinic operations.

Health Catalyst Inc beats Q3 revenue, eyes strong Q4 bookings

Health Catalyst Inc (HCAT) exceeded revenue expectations in Q3 2023 and raised full-year guidance, with strong bookings performance.
The company is focusing on optimizing costs, anticipating a large bookings quarter in Q4 2023.
Recognized for team member engagement and client success stories, with a healthy cash position.
Anticipating growth opportunities in professional services and tech-enabled managed services contracts.

Health Catalyst exceeds Q4 revenue targets, eyes sustainable growth

Health Catalyst Inc's Q4 2023 earnings call highlighted strong financial performance, exceeding revenue and EBITDA guidance, with a focus on client growth and retention.
The company's strategic objectives include migrating clients to a next-gen data platform, balancing growth between tech and services, and driving profitability through operational efficiency.
While facing challenges in client migration and balancing growth, Health Catalyst is well-positioned to capitalize on opportunities like the next-gen platform rollout and cross-selling efforts.
Overall, Health Catalyst's performance, strengths, challenges, and opportunities indicate a strategic focus on sustainable growth, profitability, and enhancing client relationships.

Health Catalyst surpasses Q1 expectations, eyes tech-driven growth

Health Catalyst demonstrated financial resilience and client-centric approach in Q1 2024.
Strategic focus on technology and services to drive growth and avoid limitations.
Opportunities in adjacent markets and client engagement for sustained expansion.
Challenges include managing R&D expenses and potential disruptions from external factors.

Health Catalyst surpasses Q2 revenue targets, eyes growth opportunities

Health Catalyst's Q2 2024 performance exceeded expectations, showcasing strong revenue and margin metrics.
The company's strategic strengths lie in client recognition, acquisitions, platform migration progress, and growth outlook.
Challenges include client retention, revenue growth, margin optimization, and disciplined capital deployment.
Opportunities for Health Catalyst include leveraging financial strength, cross-selling, technology focus, and Ignite platform benefits.

Health Catalyst exceeds Q3 expectations, eyes growth through strategic initiatives

Health Catalyst Inc's Q3 2024 earnings call showcased strong financial performance, positive outlook, and strategic initiatives for growth.
The company's focus on client relationships, market demand, and acquisitions positions it well for future success and industry leadership.
While challenges like margin expansion and competition exist, Health Catalyst Inc's strengths and opportunities indicate a promising trajectory.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.

Agree Realty

Allegiant Travel Company

Axsome Therapeutics

Coursera

Chart Industries

Karuna Therapeutics Inc

LivePerson

PDC Energy Inc

Q2 Hld

Varonis Systems

A recent pullback has created buying opportunities for many small-cap stocks. Here are the ones the pros are most bullish on.

11 Small-Cap Stocks the Analysts Love for the Rest of 2021

Health Catalyst (HCAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Health Catalyst (HCAT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

SALT LAKE CITY, July 27, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2021 second quarter operating results on Thursday, August 5, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Second Quarter 2021 Operating Results and Host Conference Call on Thursday, August 5, 2021

SALT LAKE CITY, July 21, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of Value Optimizer™, a new population health solution that quickly identifies highly valuable opportunities for value-based care (VBC) performance improvement.  VBC payment models have become increasingly common as healthcare organizations seek a better approach to managing risk and achieving profitability in population health.

Health Catalyst Launches Value Optimizer - A New Approach to Managing Risk and Achieving Profitability in Population Health

Privia Health Group

SOC Telemed

NEW YORK, July 19, 2021 /PRNewswire/ -- Health Enterprise Partners ("HEP"), a healthcare private equity firm, is pleased to announce five realizations of existing portfolio companies, and a new investment in Kno2, the tenth platform investment out of HEP III. Following a tradition of backing founder-financed businesses, HEP's investment came as part of the first source of institutional capital raised by each of these six companies.

HEP Announces Five Realizations and New Investment

SALT LAKE CITY, June 24, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that it has entered into a definitive agreement to acquire Twistle, Inc. ("Twistle"), an Albuquerque, New Mexico-based healthcare patient engagement SaaS technology company that automates patient-centered, HIPAA-compliant communication between care teams and patients to transform the patient experience, drive better care outcomes, and reduce healthcare costs.  We anticipate that Twistle's leading clinical workflow and patient engagement platform, paired with the Health Catalyst population health offering, will enable a comprehensive go-to-market solution to address the population health needs of healthcare organizations, as well as Life Science organizations, around the globe.

Health Catalyst Announces Agreement to Acquire Twistle

Amazon

Builders FirstSource

Gaming and Leisure Properties

Alphabet

JD.com

Microsoft

Rocket Pharma

Wix.com

A sharp pivot away from growth has given Wall Street a much different perspective on what constitutes today's best Nasdaq stocks. Take a look.

The Pros' Picks: The 11 Best Nasdaq Stocks You Can Buy

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q1 2021 Results - Earnings Call Transcript

SALT LAKE CITY, May 06, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2021.

Health Catalyst Reports First Quarter 2021 Results

SALT LAKE CITY, April 20, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its 2021 first quarter operating results on Thursday, May 6, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce First Quarter 2021 Operating Results and Host Conference Call on Thursday, May 6, 2021

A Relative Strength Rating upgrade for Health Catalyst shows improving technical performance. Will it continue?

IBD Rating Upgrades: Health Catalyst Shows Improved Relative Price Strength

Apple

Alibaba

Baidu

Cerner

Global X Telemedicine & Digital Health ETF

Palantir Technologies

Covid-19 has meant many tech stocks now put more resources in healthcare. These technology shares deserve to be on your radar.

7 Tech Stocks Becoming Healthcare Stocks

SALT LAKE CITY, March 31, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst") (NASDAQ: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton was named a "CEO of the Year 2021" by Utah Business. This award recognizes chief executive officers who have led their organizations with strength, courage, and endurance, and made a positive impact in Utah.

Health Catalyst's Dan Burton Named a Utah Business CEO of the Year

SALT LAKE CITY, March 10, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,") (Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the launch of the new Healthcare.AI™. Created to address healthcare business opportunities and challenges across revenue, cost, and quality, the Healthcare.AI suite of augmented intelligence (AI) products and services will significantly expand the effective use and use cases of AI in healthcare.

Health Catalyst Launches New Healthcare.AI™ to Deliver Augmented Intelligence at Scale to Healthcare Industry

The shares of Health Catalyst Inc (NASDAQ: HCAT) have received a price target increase from $50 to $54 by Piper Sandler. These are the details.

HCAT Stock Price: $54 Target (Up From $50) By Piper Sandler

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q4 2020 Results - Earnings Call Transcript

Shares of Health Catalyst (NASDAQ:HCAT) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 23.81% year over year to ($0.16), which beat the estimate of ($0.19).

Recap: Health Catalyst Q4 Earnings

SOUTH JORDAN, Utah, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2020.

Health Catalyst Reports Fourth Quarter and Year End 2020 Results

SALT LAKE CITY, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2020 operating results on Thursday, February 25, 2021, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day.

Health Catalyst to Announce Fourth Quarter and Full Year 2020 Operating Results and Host Conference Call on Thursday, February 25, 2021

BJ`s Wholesale Club Holdings Inc

Fate Therapeutics

Golar LNG

II-VI Incorporated

Nevro

Papa John's

QTS Realty Trust

If you desire growth, then your sights should be set on small-cap stocks. These 11 have attracted the gaze of dozens of Wall Street's best minds.

11 Small-Cap Stocks the Analysts Love for 2021

SALT LAKE CITY, Jan. 11, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Stephen Grossbart, Ph.D., Senior Vice President of Professional...

Health Catalyst Leader Appointed to Primary Care and Chronic Illness Standing Committee

US healthcare costs have ballooned in recent years, yet at least 25% of that spending is due to general inefficiency. Health Catalyst provides a way for healthcare organizations to manage their data and derive analytical insights all within a single platform.

Health Catalyst: Growth At The Intersection Of Health And Data

Health Catalyst (HCAT) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

Health Catalyst (HCAT) Catches Eye: Stock Jumps 5.1%

Health Catalyst, Inc. (HCAT) CEO Dan Burton on Q3 2020 Results - Earnings Call Transcript

Shares of Health Catalyst (NASDAQ:HCAT) rose 2.39% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 22.22% over the past year to ($0.21), which beat the estimate of ($0.27).

News for Health Catalyst Inc Stock (HCAT)